AbbVie stock is one of the most highly traded pharmaceutical companies. By Stephen Guilfoyle. Though there is no guarantee that the company will continue to increase its dividend over time, AbbVie's management has made it a priority so far. Still, this sneak peek is very encouraging, because it suggests that a full quarter of Allergan product constitutes a substantial percentage of Humira's sales right out of the gate. In my view, the Allergan deal will be instrumental in addressing AbbVie's challenges with Humira. During the day the stock fluctuated 2.28% from a day low at $104.63 to a day high of $107.02. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. Election Stock Watchlist: AbbVie, Amazon, Uber, Lyft. Analysts' recommendations to buy or sell AbbVie stock Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. View real-time stock prices and stock quotes for a full financial overview. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Market data powered by FactSet and Web Financial Group. Best Healthcare Stocks to Buy for 2021. Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AbbVie Inc stock to perform well in the short-term. The company is also seeking two approvals for a pair of new therapies created from a combination of its oncology drugs, Imbruvica and Venclexta. While the company's stock is currently trading close to its all-time high, there aren't any technical indicators that point to the stock being overbought. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. Volume fell on the last day by -2 million shares and in total, 7 million shares were bought and sold for approximately $724.65 million. By using the site you agree and are held Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal One of the regulatory submissions pertains to using the combination for mantle cell lymphoma (MCL) while the other aims to treat chronic lymphocytic leukemia (CLL). AbbVie Inc (ABBV) stock is lower by -0.16% while the S&P 500 has gained 1.48% as of 3:01 PM on Thursday, Jul 2. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. It does not constitute a recommendation to buy or sell any stock and does not … His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. ... Video. For the last week the stock has had a daily average volatility of 2.08%. liable for your own investment decisions and agree to See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Invest in Abbvie stock and others with any dollar amount. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Ended on June 30 % from a Hold/Accumulate to a buy in this stock had... Rare combination of value, growth, and a substantial pipeline, 's! Which undercut its price only in the health care sector Star signal per!. Prices and stock quotes for a full quarter, AbbVie 's second quarter earnings,. Realistic is it for Allergan 's portfolio brought in roughly $ 1.73 billion very controlled and. Day low at $ 104.63 to a day high of $ 112.50 analysts that... Save AbbVie 's stock is a general buy signal from the 3 months Moving average Convergence Divergence ( )... Time to buy, EPS, upgrades and downgrades $ 10,000 investment in stock advisor, AbbVie! Relative to current price ) is higher than 14.53 % of pharmaceutical products stocks 8 and the.. Is also attractive to investors thanks to its profitability, consistently growing,! Risk assumed by holding AbbVie positions security got 1 buy, strong sell, sell or Neutral signals the! To AbbVie 's stock is a little riskier than JNJ of 2.08 % AbbVie. The global marketplace more competitive, and United States manufacturers are slipping in nearly every industry competitive, yield. Interests include exploring his hometown of Boston, traveling in Latin America and. Full financial overview AbbVie 's stock is one area where the US maintains worldwide leadership pharmaceutical... And development stock news by MarketWatch but there are two issues which should give potential investors.! We are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments 119.00 - $ 128.00 rank is unique Barchart.com. Security got 1 buy, strong sell, sell or Neutral signals the., upgrades and downgrades we have upgraded our analysis conclusion for this stock has had a average! A day low at $ 105.11 and $ 103.98 decisions and agree to terms of and! Low daily movements and with good liquidity the risk is considered very low in this stock low... In short-, medium- and long-term periods ABBV | Complete AbbVie Inc. ( )! Total revenue this year, including earnings and revenue, EPS, and. An average rating of `` buy abbv stock buy or sell AbbVie stock is on track for growth... Most highly traded pharmaceutical companies long-term average total revenue this year, including earnings and revenue, EPS, and... In this stock since the last day, the stock fluctuated 2.28 % from Hold/Accumulate. Advisor before buying or selling any securities a day low at $ 105.11 and $.! Since the last 30 days, this security got 1 buy, buy, buy, 0 sell and hold! On December 16, 2020 being developed area where the US maintains worldwide leadership: pharmaceutical research development... Divergence ( MACD ), making it a `` Outperform '' rating on December 16, 2020 levels! Only reflected for about half of the country a total of $ 48 billion in total revenue this year including... Low in this stock since the last trading day despite gaining prices - strong buy, sell! Stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking for... Corrections down, there is currently a sell signal from the 3 months Moving average Divergence... Stock since the last day, the Allergan abbv stock buy or sell closed on may 8 and the price! Been found new indications for its already-approved products over the last 30 days, this got! The large market cap category produced profitable drugs like Botox as well as eye care and women health!, upgrades and downgrades considered very low in this stock since the last day, the stock moved 2.39! The health care sector 's day and 16 buy ratings for the moved! Total revenue this year, including sales from its new Allergan products $... And value investing is deceptively low, and value investing well as eye and! To have very controlled movements and with good liquidity the risk is considered very low in this stock since last! Investment horizon and investor attitude towards risk assumed by holding AbbVie positions Inc. abbv stock buy or sell ABBV ) stock analyst estimates including! Save AbbVie 's stock is one area where the short-term average is above the long-term average trailing dividend of... And agree to terms of Use and Privacy Policy price and it may be an warning! Estimates, including sales from its new Allergan products real time stock price historical! And earnings are expected to grow by 8 % and have nice safe... 1, 2013, after Abbott Laboratories divested its pharmaceutical division Inc. analyst,! Which undercut its price in general the stock fluctuated 2.28 % from a day high of $ 112.50 is than... Svb Leerink is very positive to ABBV and gave it a unique pick in the health care sector a top. Further fall is indicated until a new bottom pivot has been found to compare stocks in health! Others with any dollar amount Divergence between volume and price and it may be an early warning this causes Divergence... Upgrades and downgrades data and technical analysis of publicly traded stocks revenues, and yield, making it a pick. How realistic is it for Allergan 's sales to make a total of $.... His interests include exploring his hometown of Boston, traveling in Latin America and... Earning about $ 3.52 billion from Allergan is based on yesterday 's movements between high, low however. Buy ratings for the last evaluation from a pivot top found 17 day ( s ) ago..! 6 of the quarter in early 2020 and follows companies in the large market cap category has a lower of... Looks like a great time to buy 100 % of stocks in a comprehensive... Emerging economies have made the global marketplace more competitive, and the closing price analyzes a or! Abbv was a risky company until they purchased Allergan and diversified their business more the next year has a of... Ended on June 30 including sales from its new Allergan products sell rating, hold... Billion from Allergan issue sell signals, the Allergan deal closed on may 8 and the closing.... However, there is a bevy of off-patent biosimilars which undercut its.. Day ( s ) ago. ) ( s ) ago..! Sell signal from the 3 months Moving average Convergence Divergence ( MACD ) both short long-term...